CIK 0001742927 · Non-accelerated filer<br>Smaller reporting company
REVIVA PHARMACEUTICALS HOLDINGS, INC.
Sign in to watch- Ticker
- RVPH
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 4085018881
- Business address
- 10080 N WOLFE ROAD, SUITE SW3-200, CUPERTINO, CA, 95014
- Former names
- Tenzing Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-13 | Margolin Richard A Director | Grant or award · Stock Option (right to buy) | +8,200 | 8,200 | ||
| 2023-11-13 | Patel Purav Director | Grant or award · Stock Option (right to buy) | +8,200 | 8,200 | ||
| 2023-11-13 | SAXENA PARAG Director | Grant or award · Stock Option (right to buy) | +8,200 | 8,200 | ||
| 2023-04-25 | Bhat Laxminarayan President and CEO | Grant or award · Stock Option (right to buy) | +443,000 | 443,000 | ||
| 2023-04-25 | Bhat Laxminarayan President and CEO | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2023-04-25 | Narayan Prabhu Chief Financial Officer | Grant or award · Stock Option (right to buy) | +170,000 | 170,000 | ||
| 2022-11-18 | Patel Purav Director | Purchase | +3,000 | $4.69 | $14K | 43,547 |
| 2022-11-10 | SAXENA PARAG Director | Grant or award · Stock Option (right to buy) | +3,900 | 3,900 | ||
| 2022-11-10 | Patel Purav Director | Grant or award · Stock Option (right to buy) | +3,900 | 3,900 | ||
| 2022-11-10 | Margolin Richard A Director | Grant or award · Stock Option (right to buy) | +3,900 | 3,900 | ||
| 2022-11-10 | Funtleyder Leslie D. Director | Grant or award · Stock Option (right to buy) | +3,900 | 3,900 | ||
| 2022-09-30 | Narayan Prabhu Chief Financial Officer | Purchase | +50,000 | $1.66 | $83K | 100,000 |
| 2022-09-08 | VEDANTA PARTNERS, LLC 10% owner | Purchase · Pre-Funded Warrant | +869,565 | $2.53 | $2.2M | 869,565 |
| 2022-09-08 | VEDANTA PARTNERS, LLC 10% owner | Purchase · Pre-Funded Warrant | +513,834 | $2.53 | $1.3M | 513,834 |
| 2022-09-08 | VEDANTA PARTNERS, LLC 10% owner | Purchase · Common Stock Warrant (right to buy) | +869,565 | $0.00 | $87 | 869,565 |
| 2022-09-08 | VEDANTA PARTNERS, LLC 10% owner | Purchase · Common Stock Warrant (right to buy) | +513,834 | $0.00 | $51 | 513,834 |
| 2022-06-30 | Narayan Prabhu Chief Financial Officer | Purchase | +50,000 | $1.21 | $61K | 50,000 |
| 2021-12-08 | Patel Purav Director | Grant or award · Stock Option (right to buy) | +5,300 | 5,300 | ||
| 2021-12-08 | Margolin Richard A Director | Grant or award · Stock Option (right to buy) | +5,300 | 5,300 | ||
| 2021-12-08 | Funtleyder Leslie D. Director | Grant or award · Stock Option (right to buy) | +5,300 | 5,300 |
Page 2 of 5 · 83 trades